Perfil
Tracy Cunningham is currently the Director at Health Research Board and the Chief Medical Officer at Amryt Pharma Plc.
Previously, she worked as the Clinical Head-Oncology Research & Development at AstraZeneca PLC and as the Vice President & Head-Development at Amryt Pharma Holdings Ltd. Dr. Cunningham completed her undergraduate degree at the Royal College of Surgeons.
Cargos activos de Tracy Cunningham
| Empresas | Cargo | Inicio |
|---|---|---|
| AMRYT PHARMA PLC | Director Técnico/Científico/I+D | 01/04/2020 |
Health Research Board
Health Research Board General GovernmentGovernment Provides research services on health | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Tracy Cunningham.
| Empresas | Cargo | Fin |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Director Técnico/Científico/I+D | - |
Formación de Tracy Cunningham.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Royal College of Surgeons
Royal College of Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Health Research Board
Health Research Board General GovernmentGovernment Provides research services on health | Government |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Health Technology |
Amryt Pharma Plc
Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company and develops and commercializing treatments for patients with rare & orphan diseases | Health Technology |
- Bolsa de valores
- Insiders
- Tracy Cunningham
















